Dysphagia optimized radiotherapy to reduce swallowing dysfunction severity in patients undergoing treatment for head and neck cancer: A systematized scoping review-Reference-Cited by-同舟云学术

Dysphagia optimized radiotherapy to reduce swallowing dysfunction severity in patients undergoing treatment for head and neck cancer: A systematized scoping review

Published:2019-02-05 Issue:6 Volume:41 Page:2024-2033
ISSN:1043-3074
Container-title:Head & Neck
language:en
Short-container-title:Head & Neck

Author:

Hutchison Alana R.¹²^ORCID,Cartmill Bena¹²³,Wall Laurelie R.¹²^ORCID,Ward Elizabeth C.¹²

Affiliation:

1. Division of Speech Pathology, School of Health and Rehabilitation SciencesThe University of Queensland St Lucia Queensland Australia

2. Centre for Functioning and Health ResearchQueensland Health Buranda Queensland Australia

3. Speech Pathology DepartmentPrincess Alexandra Hospital Woolloongabba Queensland Australia

Publisher

Wiley

Subject

Otorhinolaryngology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hed.25688

Reference45 articles.

1. Dose to Larynx Predicts for Swallowing Complications After Intensity-Modulated Radiotherapy

2. Systematic Review of Dose–Volume Correlates for Structures Related to Late Swallowing Disturbances After Radiotherapy for Head and Neck Cancer

3. Impact of dysphagia on quality of life after treatment of head-and-neck cancer

4. Dysphagia and aspiration followingchemo-irradiation of head and neck cancer: major obstacles to intensification of therapy

5. CT-based delineation of organs at risk in the head and neck region: DAHANCA, EORTC, GORTEC, HKNPCSG, NCIC CTG, NCRI, NRG Oncology and TROG consensus guidelines

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Post-operative intensity-modulated vs 3D conformal radiotherapy after conservative surgery for laryngeal tumours of the supraglottic region: a dosimetric analysis on 20 patients;Acta Otorhinolaryngologica Italica;2024-04

2. Omission of radiotherapy to lymph node level III in patients with cN0 adenoid cystic carcinoma of the major salivary gland: a single center experience;La radiologia medica;2024-02-03

3. Dysphagia-optimised intensity-modulated radiotherapy versus standard intensity-modulated radiotherapy in patients with head and neck cancer (DARS): a phase 3, multicentre, randomised, controlled trial;The Lancet Oncology;2023-08

4. Feasibility of ipsilateral elective neck irradiation of levels Ib and II without level III in patients with node‐negative sinonasal squamous cell carcinoma;Head & Neck;2022-12-19

5. Using dosimetric information to guide dysphagia management in patients with head and neck cancer: Clinicians’ knowledge and experiences;International Journal of Speech-Language Pathology;2021-10-15